Molecular basis of promiscuous chemokine-engagement by the Duffy antigen receptor

This study utilizes a novel sortase-mediated chemical-ligation strategy to generate sulfated Duffy antigen receptor (DARC) and determine its high-resolution cryo-EM structures with chemokines CCL7 and CXCL8, revealing a unique single-site binding mechanism distinct from other chemokine receptors and elucidating how tyrosine sulfation and Fya/Fyb allelic variations modulate binding affinity through specific N-terminus repositioning.

The Gist

The Story of the "Universal Doorman" and the "Sulfate Key"

Imagine your body is a bustling city. In this city, there are millions of tiny messengers called chemokines. These messengers carry important news, like "Send help to the infection site!" or "Move the immune cells here!" To deliver their news, they need to knock on specific doors (receptors) on the surface of cells.

Most doors in this city are very picky. A "C-C" messenger can only knock on a "C-C" door, and a "C-X-C" messenger can only knock on a "C-X-C" door. They have strict security systems.

But there is one very special, unusual doorman named DARC (or the Duffy Antigen). DARC is unique because:

1. He is a promiscuous doorman: He will open the door for any messenger, whether they are C-C or C-X-C. He doesn't care about the type of news; he just wants to grab the messenger.
2. He doesn't ring the alarm: Usually, when a messenger knocks, the doorman rings an alarm inside the house (activating a G-protein) to start a reaction. DARC grabs the messenger but never rings the alarm. He just holds onto them, effectively acting as a trash can or a parking lot for these messengers to clear the streets.
3. He is a target for malaria: The malaria parasite (Plasmodium vivax) uses DARC as its front door to get into red blood cells.

The Big Mystery:
Scientists knew DARC was weird, but they didn't know how he managed to grab so many different types of messengers so effectively. They also knew that DARC has a special "hat" on his head made of sulfate (a chemical tag), and that this hat seemed to make him better at grabbing messengers, but they couldn't see exactly how it worked because the hat was too floppy to photograph.

The Scientific Breakthrough: Building a Better Camera

To solve this, the researchers had to build a special tool.

• The Problem: When they tried to grow DARC in a lab, the "sulfate hat" didn't stick on properly. It was like trying to take a photo of a blurry, floppy hat.
• The Solution: They invented a "molecular glue" technique (called sortase-mediated chemical ligation). Imagine they cut off the top of the DARC doorman, made a perfect, custom-made sulfate hat in a lab, and then glued it back on with surgical precision. Now, the hat was perfectly stiff and visible.

With this perfectly prepared DARC, they used a super-powerful microscope (Cryo-EM) to take 3D snapshots of DARC holding hands with two different messengers: CCL7 and CXCL8.

What They Discovered: The "One-Handed" Hug

Here is what the snapshots revealed, using simple analogies:

1. The "Surface Hug" vs. The "Deep Dive"

• Normal Receptors (The Deep Divers): Usually, when a messenger knocks on a normal door, it dives deep into the keyhole (the orthosteric pocket) and locks in tight from the inside. It's like a key going all the way into a lock.
• DARC (The Surface Hugger): DARC is different. He doesn't let the messenger dive deep. Instead, he grabs them with his long arm (the N-terminus) and holds them on the surface. It's like a hug from the outside rather than a handshake inside the house.
• Why this matters: Because he doesn't force the messenger into a specific deep pocket, he can accommodate many different shapes of messengers. It's like having a universal adapter plug that fits many different types of outlets, rather than a specific key for one lock.

2. The "Sulfate Hat" is the Secret Sauce

• When the researchers looked at DARC with his sulfate hat on, they saw something amazing. The hat didn't just sit there; it acted like a magnetic anchor.
• The sulfate on the hat reached out and grabbed onto the messenger with a strong electrical pull. This pulled the messenger closer and rearranged the way they held hands.
• The Analogy: Imagine trying to hold a slippery bar of soap. Without a glove, it's hard. But if you put on a sticky rubber glove (the sulfate), you can hold it much tighter and in a different position. This "sticky glove" makes DARC a much better catcher.

3. The Blood Type Difference (Fya vs. Fyb)

• People have different versions of DARC based on their blood type (Fya or Fyb). The difference is just one tiny letter in the code (Glycine vs. Aspartic Acid).
• The Analogy: Think of Fya as a doorman with a slightly loose, flexible arm. Think of Fyb as a doorman with a slightly stiffer, more rigid arm.
• The study showed that the Fyb version (the stiffer arm) actually grabs the messengers tighter and holds them in a slightly different spot. This explains why people with the Fyb blood type might clear inflammation messengers from their blood more efficiently than those with Fya.

4. Why Malaria and Cancer Care

• Since DARC is the door for the malaria parasite, understanding exactly how DARC grabs things helps us figure out how to block that door so malaria can't get in.
• Since DARC acts as a "sponge" for cancer-related messengers, understanding its grip helps scientists figure out how to stop cancer from spreading or how to make the immune system fight harder.

The Bottom Line

This paper is like a high-definition security video that finally shows us exactly how the "Universal Doorman" (DARC) works.

• He doesn't use a deep lock; he uses a flexible, surface-level hug.
• He wears a special "sulfate hat" that acts like a super-sticky glove to grab messengers tighter.
• Small changes in his "uniform" (blood type) change how well he catches them.

This knowledge gives scientists a new blueprint to design drugs that can either block malaria from entering cells or help the body manage inflammation and cancer more effectively.

Technical Summary

1. Problem Statement

The Duffy Antigen Receptor for Chemokines (DARC), also known as Atypical Chemokine Receptor 1 (ACKR1), is a seven-transmembrane (7TM) receptor expressed on erythrocytes and endothelial cells. It serves as the critical entry receptor for the malaria parasite Plasmodium vivax and acts as a chemokine scavenger, modulating inflammatory gradients. Unlike prototypical chemokine receptors, DARC is "atypical" because it does not signal through canonical G-proteins, GRKs, or $\beta$-arrestins.

Despite its biological importance, three fundamental questions remained unanswered:

1. Promiscuity Mechanism: How does DARC bind promiscuously to both C-C (e.g., CCL7) and C-X-C (e.g., CXCL8) chemokine subtypes, whereas most receptors are highly selective?
2. Post-Translational Modulation: How does N-terminal tyrosine sulfation (at Tyr30 and Tyr41) modulate chemokine binding affinity and specificity?
3. Allelic Variation: How does the Gly42Asp polymorphism (defining the Fya vs. Fyb blood groups) alter the structural basis of chemokine recognition and impact disease progression (e.g., malaria susceptibility and cancer)?

Previous structural studies were limited by the inability to resolve the sulfated N-terminus due to inefficient sulfation in insect cell expression systems (Sf9 cells).

2. Methodology

The authors employed a multidisciplinary approach combining synthetic biology, structural biology, and biophysics:

• Sortase-Mediated Chemical Ligation: To overcome the limitation of inefficient sulfation in Sf9 cells, the team developed a novel strategy. They engineered a DARC construct with a TEV protease site and a sortase recognition motif. After TEV cleavage, they ligated a synthetic N-terminal peptide (containing sulfated Tyr30 and Tyr41) to the receptor using Sortase A. This produced SulfoDARC with uniform, site-specific tyrosine sulfation.
• Cryo-Electron Microscopy (Cryo-EM): The authors determined high-resolution structures of multiple complexes:
  • CCL7 bound to Wild-Type DARC (WTDARCG42).
  • CXCL8 bound to WTDARCG42.
  • CXCL8 bound to SulfoDARC (Gly42 variant).
  • CXCL8 bound to SulfoDARC (Asp42/Fyb variant).
  • CXCL8 bound to Non-sulfated Fyb variant.
• Biophysical Validation: NanoBRET binding assays were performed on HEK293T cells to validate the functional impact of specific mutations (e.g., N-terminal alanine substitutions) and allelic variants on chemokine binding affinity.
• Comparative Structural Analysis: Structures were compared against prototypical chemokine receptors (specifically CXCR2) to identify unique architectural features.

3. Key Contributions

• Development of a Generalizable Platform: The paper introduces a sortase-mediated chemical ligation platform that allows for the precise installation of post-translational modifications (like tyrosine sulfation) on GPCRs, enabling structural studies that were previously impossible with recombinant expression alone.
• Resolution of Sulfated Structures: For the first time, high-resolution cryo-EM structures were obtained showing the N-terminal tyrosine sulfation of DARC in complex with chemokines, revealing how this modification remodels the binding interface.
• Mechanistic Insight into Promiscuity: The study elucidates why DARC can bind diverse chemokine subtypes, contrasting it with the strict selectivity of canonical receptors.

4. Key Results

A. Molecular Basis of Promiscuous Binding

• One-Site Binding Mode: Unlike prototypical receptors (e.g., CXCR2) that utilize a "two-site" binding mechanism (N-terminus of chemokine to receptor N-terminus + chemokine core to orthosteric pocket), DARC engages chemokines primarily through a single-site mechanism.
• Superficial Engagement: The chemokine core (CCL7 or CXCL8) binds superficially to the receptor's N-terminus. The chemokine's own N-terminus forms a "hook-like" conformation that diverges away from the orthosteric pocket, preventing deep penetration.
• Conformational Plasticity: The DARC N-terminus is exceptionally long and flexible. It adopts different conformations to accommodate different chemokines (e.g., a helical segment docking into a hydrophobic pocket for CXCL8 vs. a linear transition for CCL7).
• Lack of Canonical Motifs: DARC lacks the conserved "R-D" motif (Arg-Asp) found in CXCR2 that typically engages the E-L-R motif of C-X-C chemokines. Instead, DARC uses a "pseudo-R-D" motif, resulting in a shallower, more adaptable binding interface.

B. Structural Features Precluding Signaling

• Cytoplasmic Pocket Abolition: The intracellular side of DARC lacks the canonical "micro-switches" required for G-protein coupling.
  • The conserved DRY motif is replaced by L-G-H.
  • TM3, TM5, and TM6 are significantly shortened compared to CXCR2.
  • The intracellular loops (ICL1, ICL2) are displaced, and the cytoplasmic pocket required for G-protein or $\beta$-arrestin binding is effectively abolished. This explains DARC's inability to trigger canonical signaling.

C. Impact of Tyrosine Sulfation

• Remodeling of the Interface: Sulfation of Tyr41 (sTyr41) induces a ~140° rotation of the side chain, creating a new sub-pocket.
• Enhanced Affinity: In the sulfated state, sTyr41 forms direct ionic interactions with His18 and Lys23 of CXCL8. This reorientation pulls the N-terminal segment closer to the chemokine core, significantly increasing binding affinity compared to the non-sulfated form.
• Differential Resolution: The sulfated Tyr41 was clearly resolved in CXCL8 complexes but less so in CCL7 complexes, suggesting chemokine-specific sensitivity to sulfation.

D. Impact of Fya/Fyb Allelic Variation (Gly42Asp)

• Rigidification: The Fyb variant (Asp42) introduces a rigid hinge compared to the flexible Gly42 in Fya.
• Lateral Displacement: The Asp42 substitution causes a lateral shift of the N-terminal segment (~3.3 Å to ~9 Å depending on sulfation status) toward the chemokine core.
• New Interaction Networks: In the Fyb variant, Asp42 forms ionic interactions with Lys15 of CXCL8. Upon sulfation, this effect is amplified, with the N-terminus shifting further to engage Lys20 and other residues, explaining the higher sequestration capacity of the Fyb allele for pro-inflammatory chemokines.

5. Significance

• Therapeutic Implications: Understanding the structural basis of DARC's promiscuity and its role as a chemokine scavenger offers new avenues for targeting inflammatory diseases, cancer metastasis (where chemokine gradients drive cell migration), and malaria (P. vivax entry).
• Blood Group Relevance: The study provides a structural explanation for the functional differences between Fya and Fyb blood groups, linking the Gly42Asp polymorphism to altered chemokine sequestration and potentially differential disease outcomes.
• Methodological Advance: The sortase-mediated ligation strategy is a generalizable tool for studying other GPCRs that require specific post-translational modifications (like sulfation or glycosylation) for native function, bridging the gap between recombinant protein production and physiological reality.
• Paradigm Shift: The findings challenge the canonical view of chemokine-receptor interactions, demonstrating that a "one-site" superficial binding mode can drive high-affinity, promiscuous recognition, distinct from the deep-pocket binding seen in signaling receptors.